Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference32 articles.
1. Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European reference network on hepatological diseases and the international autoimmune hepatitis group;Lohse;J. Hepatol.,2020
2. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group;Pape;J. Hepatol.,2022
3. Advancing biologic therapy for refractory autoimmune hepatitis;Czaja;Dig Dis Sci.,2022
4. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases;Lindor;Hepatology,2019
5. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis;J. Hepatol.,2017
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple drugs;Reactions Weekly;2024-06-29
2. Pathogenic roles of follicular helper T cells in IgG4-related disease and implications for potential therapy;Frontiers in Immunology;2024-06-07
3. Autoimmune Hepatitis Management: Recent Advances and Future Prospects;Livers;2024-05-15
4. Causal association between autoimmune liver disease and Sjögren's syndrome: A Mendelian randomization study;International Journal of Rheumatic Diseases;2024-05
5. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?;Exploration of Digestive Diseases;2024-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3